To access this element change to forms mode OFF
Grant Award View - GA201537
Leveraging human genetics to inform treatment in fatty liver disease
GA ID:
GA201537
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,270,120.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Leveraging human genetics to inform treatment in fatty liver disease
Purpose:
Fatty liver disease affects 1 in 3 Australians and a quarter will develop liver failure or cancer; it has no drug treatments. The disease is characterized by tremendous variability in its clinical course, in part due to a lack of understanding of its genetic basis. To move towards personalised medicine, this program will undertake human and small animal studies to develop novel gene-based tests for diagnostics and risk classification and identify genes that are targets for drug development.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2008983
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA